Company Quick10K Filing
Ulta Beauty
10-Q 2021-05-01 Filed 2021-05-27
10-K 2021-01-30 Filed 2021-03-26
10-Q 2020-10-31 Filed 2020-12-03
10-Q 2020-08-01 Filed 2020-08-27
10-Q 2020-05-02 Filed 2020-05-28
10-K 2020-02-01 Filed 2020-03-27
10-Q 2019-11-02 Filed 2019-12-05
10-Q 2019-08-03 Filed 2019-08-29
10-Q 2019-05-04 Filed 2019-05-30
10-K 2019-02-02 Filed 2019-04-02
10-Q 2018-11-03 Filed 2018-12-06
10-Q 2018-08-04 Filed 2018-08-30
10-Q 2018-05-05 Filed 2018-06-01
10-K 2018-02-03 Filed 2018-04-03
10-Q 2017-10-28 Filed 2017-11-30
10-Q 2017-07-29 Filed 2017-08-31
10-Q 2017-04-29 Filed 2017-06-01
10-K 2017-01-28 Filed 2017-03-28
10-Q 2016-10-29 Filed 2016-12-01
10-Q 2016-07-30 Filed 2016-08-25
10-Q 2016-04-30 Filed 2016-06-02
10-K 2016-01-30 Filed 2016-03-30
10-Q 2015-10-31 Filed 2015-12-03
10-Q 2015-08-01 Filed 2015-09-03
10-Q 2015-05-02 Filed 2015-06-04
10-K 2015-01-31 Filed 2015-04-01
10-Q 2014-11-01 Filed 2014-12-04
10-Q 2014-08-02 Filed 2014-09-11
10-Q 2014-05-03 Filed 2014-06-10
10-K 2014-02-01 Filed 2014-04-02
10-Q 2013-08-03 Filed 2013-09-12
10-Q 2013-05-04 Filed 2013-06-11
10-K 2013-02-02 Filed 2013-04-03
10-Q 2012-10-27 Filed 2012-11-29
10-Q 2012-07-28 Filed 2012-09-06
10-Q 2012-04-28 Filed 2012-06-05
10-K 2012-01-28 Filed 2012-03-28
10-Q 2011-10-29 Filed 2011-12-01
10-Q 2011-07-30 Filed 2011-09-08
10-Q 2011-04-30 Filed 2011-06-07
10-K 2011-01-29 Filed 2011-03-30
10-Q 2010-10-30 Filed 2010-12-02
10-Q 2010-07-31 Filed 2010-09-02
10-Q 2010-05-01 Filed 2010-06-03
10-K 2010-01-30 Filed 2010-03-31
8-K 2020-09-23
8-K 2020-08-27
8-K 2020-07-20
8-K 2020-06-18
8-K 2020-06-03
8-K 2020-05-28
8-K 2020-05-07
8-K 2020-04-08
8-K 2020-04-02
8-K 2020-03-18
8-K 2020-03-17
8-K 2020-03-12
8-K 2020-03-11
8-K 2019-12-05
8-K 2019-11-27
8-K 2019-09-18
8-K 2019-08-29
8-K 2019-06-05
8-K 2019-05-30
8-K 2019-04-12
8-K 2019-03-15
8-K 2019-03-14
8-K 2018-12-06
8-K 2018-11-08
8-K 2018-09-22
8-K 2018-08-30
8-K 2018-06-06
8-K 2018-05-31
8-K 2018-03-15

Ulta Beauty Financials

ULTA Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-04-302011-07-302011-10-292012-01-282012-04-282012-07-282012-10-272013-02-022013-05-042013-08-032013-10-312014-02-012014-05-032014-08-022014-11-012015-01-312015-05-022015-08-012015-10-312016-01-302016-04-302016-07-302016-10-292017-01-282017-04-292017-07-292017-10-282018-02-032018-05-052018-08-042018-11-032019-02-022019-05-042019-08-032019-11-02
Cash1171431312542661971923202932862414194573632953893863252103462391941333853229347277232237297409327177209
Accounts Receivable31
Inventory
PP&E3323523746733854214678384995425901,0236046476871,2437457928441,5028719201,0021,8031,0211,0951,1732,1491,1911,2131,2582,3751,2061,2201,233
Assets7668169309571,0581,0391,2331,2751,3321,3921,5351,6031,6991,7801,9231,9832,0782,1162,2402,2312,2192,3062,5512,5522,7082,7022,8352,9093,0223,0733,3333,1914,7664,7104,929
Accounts Payable82811348611289185119148131190148184163236191210216291196266285425260319313447326373410574404407450595
Long-Term Debt
Liabilities3163384063734733995264885285326076006396547367367757728667888999141,0991,0021,0661,0671,2191,1341,2391,2611,4971,3712,8252,8713,082
Stockholders' Equity4494785245855856407077878048609281,0031,0601,1261,1861,2481,3031,3441,3741,4431,3201,3921,4521,5501,6421,6351,6161,7741,7831,8121,8361,8201,9421,8391,847
Income Statement ($MM)2011-04-302011-07-302011-10-292012-01-282012-04-282012-07-282012-10-272013-02-022013-05-042013-08-032013-10-312014-02-012014-05-032014-08-022014-11-012015-01-312015-05-022015-08-012015-10-312016-01-302016-04-302016-07-302016-10-292017-01-282017-04-292017-07-292017-10-282018-02-032018-05-052018-08-042018-11-032019-02-022019-05-042019-08-032019-11-02
Revenue3863954135834745435067595836786198687148297461,0488688779111,2681,0741,0691,1311,5811,3151,4741,3421,9381,5441,4881,5602,1251,7431,6671,683
Cost of Revenue2512602643843033533204993793893875754685564646985655715758296836847041,0368399558491,2799839539881,3841,0981,0611,059
Gross Profit135134149198171189185260204231232294246274282350303306336439390385427545476518493658561535572741645606623
R&D
SG&A9591101124111116118154133134151178162158181211192184219268241236280316283286321400346337395457403393449
Tax161617272330233926472744313735504145406256545284611316049471164668474839
Net Income23242746354338654249457150655987677471108929088140128155105208164148131215192161130
Cash Flow ($MM)2011-04-302011-07-302011-10-292012-01-282012-04-282012-07-282012-10-272013-02-022013-05-042013-08-032013-10-312014-02-012014-05-032014-08-022014-11-012015-01-312015-05-022015-08-012015-10-312016-01-302016-04-302016-07-302016-10-292017-01-282017-04-292017-07-292017-10-282018-02-032018-05-052018-08-042018-11-032019-02-022019-05-042019-08-032019-11-02
Cash Operating456171431324411624342167460132506857232271675310331217644450277111154272176110
Cash Investing-20-33-45-31-25-47-73-45-42-56-79-39-155-78-127-57-81-95-47-54-75-132-13-197-146-163-1912121-280-5550
Cash Financing212171125-462612-2871832-3-30-15-38-44-44-219-23-33-47-42-127-57-131-126-115-75-270-128